OEM vs ODM Medical Devices: 7 Factors to Pick the Right Path (2026)

Bringing a new medical device to market is a significant undertaking, and one of the first critical decisions you will face is how to approach manufacturing. Two prevalent models dominate the industry: OEM (Original Equipment Manufacturing) and ODM (Original Design Manufacturing). At Dinghmed, we have seen firsthand how the wrong choice can delay a product launch by 12–18 months or inflate compliance costs by 40 percent, so understanding the distinction is not just academic—it is the single most important step toward a successful and efficient product launch.

What is OEM (Original Equipment Manufacturing)?

OEM is the “your design, our execution” model: you provide the manufacturer with a fully developed design and proprietary IP, and the manufacturer replicates it at scale, meaning you retain full regulatory responsibility as the legal manufacturer under FDA and Health Canada frameworks.

Think of OEM as the “Your Design, Our Execution” model. In this arrangement, you, the brand company, provide the manufacturer with a complete and fully-developed product design. This includes detailed technical specifications, blueprints, material lists, and often the proprietary intellectual property (IP) behind the product. From a regulatory standpoint—and this is where many startups stumble—the OEM model designates you as the “legal manufacturer” in the eyes of the FDA and Health Canada. That means you are responsible for all premarket submissions (such as 510(k) notifications), post-market surveillance, and mandatory reporting under the Manufacturer and User Facility Device Experience (MAUDE) database. According to the FDA’s Guidance for Industry Private Label Medical Devices, the brand owner who holds the 510(k) clearance carries the full weight of compliance, even if the product is physically built by a contract manufacturer. This model also requires significant upfront investment in infrastructure—cleanrooms, quality systems, and testing labs—which can run into the millions of dollars. However, for companies with strong R&D capabilities, OEM offers unmatched control over design changes and intellectual property. Dinghmed’s work with Class II device developers shows that OEM is ideal when your product incorporates a novel algorithm or proprietary material that must be protected as a trade secret.

• Your Role: You are responsible for the entire R&D, design, and prototyping phase.
• Manufacturer’s Role: Their primary responsibility is to precisely replicate your design at scale, ensuring consistency, Quality & Compliance with your specified requirements.

What is ODM (Original Design Manufacturing)?

ODM is the “our solution, your brand” model: the manufacturer provides a pre-engineered design platform that you can customize under your own brand, which drastically reduces time-to-market and shifts most regulatory documentation responsibilities to the ODM partner.

ODM, on the other hand, is the “Our Solution, Your Brand” model. Here, you partner with a manufacturer that already has existing product designs, platforms, and expertise. You can leverage these resources to create a market-ready product under your own brand name, often with a degree of customization. This approach is particularly popular among distributors and startups because it bypasses years of R&D and the need to build specialized medical device factory infrastructure. In the ODM model, the manufacturer typically owns the base IP and holds the master design history file. For regulatory bodies like Health Canada, this means the ODM partner may serve as the “private label manufacturer,” and the brand owner must ensure that the ODM’s existing 510(k) or Medical Device Licence (MDL) is transferable or that a new submission references the master file. The Guidance Document – Private Label Medical Devices from Gouvernement du Canada Search explicitly outlines the responsibilities of label manufacturers in this scenario: the brand owner must still register their establishment and list the device, but the ODM provides much of the technical documentation. This model significantly reduces your money and time investment—according to a 2024 survey of medical device assembly companies, ODM projects reach the market 40% faster on average than OEM projects. Dinghmed has applied this model for clients launching hemostatic gauze product lines, including an emergency birth kit, where speed was critical to meet humanitarian procurement deadlines.

• Your Role: You define the market need, target audience, and branding. You may select from existing product platforms and request modifications.
• Manufacturer’s Role: They handle the bulk of the heavy lifting: design, engineering, prototyping, and manufacturing. They own the base IP of the product design.

OEM vs. ODM: A Side-by-Side Comparison

To make the right choice, you need to weigh core trade-offs across design control, regulatory burden, investment, and timeline—here is a structured comparison that consolidates best practices from Dinghmed’s engagements with both startups and Fortune 500 medical device manufacturers.

The following table provides a clear visual overview of how these two models compare across key decision-making factors. We have added regulatory and financial dimensions that are often overlooked in generic comparisons.

Aspect	OEM (Original Equipment Manufacturing)	ODM (Original Design Manufacturing)
Design Control	Complete control—you own the design and can modify it at any time.	Limited customization—you work within the ODM’s existing platform.
IP Ownership	You retain all IP; the manufacturer cannot sell your design to others.	The ODM owns the base IP; your customizations might be shared with other clients unless a exclusivity agreement is signed.
Regulatory Responsibility	You are the legal manufacturer—responsible for 510(k), MDR, MAUDE reporting, and facility registration with FDA and Health Canada.	The ODM provides the master file; you are the “label manufacturer” under Health Canada’s Guidance Document – Private Label Medical Devices, responsible for establishment registration and labeling compliance.
Upfront Investment	High—requires infrastructure (cleanrooms, QA labs), prototyping, and regulatory filing fees that can exceed $500,000 for a Class II device.	Low to moderate—no need to build manufacturing infrastructure; fees are limited to customization and regulatory submission (often under $100,000).
Time to Market	Long—typically 24–36 months from concept to commercial launch.	Short—often 6–12 months if the ODM has a pre-approved design platform.
Best For	Established companies with proprietary medical device technology and in-house regulatory teams.	Startups, distributors, and companies expanding product lines quickly with limited capital.

Path	Steps
Existing Design and IP	Path A: OEM Model → Key Advantage: Full Control and IP Protection → Best For: Established Companies With R&D Resources
Market Need and Brand	Path B: ODM Model → Key Advantage: Speed and Cost Efficiency → Best For: Startups, Distributors, Companies Expanding Lines

From a practical standpoint, the decision often comes down to your company’s risk appetite and regulatory readiness. In our practice at Dinghmed, we have seen startups mistakenly choose OEM because they want “full control,” only to be buried by the cost of maintaining a compliant quality system and the complexity of FDA reporting. Conversely, we have advised established manufacturers to stay with OEM because their product’s unique mechanism—such as a novel hemostatic coating—requires complete proprietary control. The key is to map your product’s regulatory classification and your financial runway to the appropriate model. For example, under Health Canada’s Application Information Guidance, a Class II device with well-known predicates is an excellent candidate for ODM, while a new Class III device with no predicate likely demands OEM.

We also recommend conducting a “30-day regulatory audit” before making your choice. Review the FDA’s Guidance for Industry Private Label Medical Devices and Health Canada’s equivalent document with your legal team. Determine whether your ODM partner’s existing 510(k) or MDL can be referenced in your own application—this alone can save you six months and $50,000 in filing fees. The missing entities that many guides ignore—such as the role of the label manufacturer under Canadian regulations, the distinction between “manufacturer” and “private label distributor” in the MAUDE database, and the impact of your choice on post-market surveillance infrastructure—are precisely the factors that will make or break your project. Dinghmed has built its entire decision framework around these granular regulatory realities, ensuring our clients avoid costly rework.

Ready to evaluate which manufacturing model aligns with your device and regulatory strategy? Our team at Dinghmed has helped dozens of companies navigate the OEM vs. ODM decision. Contact us for a free 30-minute consultation that includes a regulatory roadmap tailored to your product class and target markets.